National_Coverage_Determinations_Manual / Nesiritide for Treatment of Heart Failure Patients

Why This Topic Matters

Coverage determinations affect whether claims are payable and how services are reported or supported in the medical record. This page helps readers understand the Medicare policy boundaries for a specific heart failure drug therapy.

Article Sections

1. A. General

   Provides the policy context for the medication and identifies the clinical setting referenced in the determination. It also notes the broader treatment context addressed by the manual entry.

2. B. Nationally Covered Indications

   States the nationally covered indications category for this manual entry. The section is brief and serves primarily as a policy classification statement.

3. C. Nationally Non-covered Indications

   Summarizes the non-covered policy determination and its effective date. It identifies the type of use addressed by the CMS determination.

4. D. Other

   Describes the scope of the determination and notes what it does not change. This section clarifies the policy’s relationship to other uses and FDA-approved treatment context.